DK0700290T3 - Rektale præparater indeholdende odansentron som fri base - Google Patents

Rektale præparater indeholdende odansentron som fri base

Info

Publication number
DK0700290T3
DK0700290T3 DK94918355T DK94918355T DK0700290T3 DK 0700290 T3 DK0700290 T3 DK 0700290T3 DK 94918355 T DK94918355 T DK 94918355T DK 94918355 T DK94918355 T DK 94918355T DK 0700290 T3 DK0700290 T3 DK 0700290T3
Authority
DK
Denmark
Prior art keywords
odance
centron
free base
preparations containing
rectal preparations
Prior art date
Application number
DK94918355T
Other languages
English (en)
Inventor
Isabelle Thielemans
Isabelle Richard
Original Assignee
Glaxo Wellcome Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Wellcome Lab filed Critical Glaxo Wellcome Lab
Application granted granted Critical
Publication of DK0700290T3 publication Critical patent/DK0700290T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/02Suppositories; Bougies; Bases therefor; Ovules
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
DK94918355T 1993-05-25 1994-05-24 Rektale præparater indeholdende odansentron som fri base DK0700290T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB939310756A GB9310756D0 (en) 1993-05-25 1993-05-25 Compositions
PCT/EP1994/001652 WO1994027599A1 (en) 1993-05-25 1994-05-24 Rectal compositions

Publications (1)

Publication Number Publication Date
DK0700290T3 true DK0700290T3 (da) 2000-03-13

Family

ID=10736089

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94918355T DK0700290T3 (da) 1993-05-25 1994-05-24 Rektale præparater indeholdende odansentron som fri base

Country Status (38)

Country Link
US (1) US5741806A (da)
EP (1) EP0700290B1 (da)
JP (1) JP2965703B2 (da)
KR (1) KR100297212B1 (da)
CN (1) CN1106194C (da)
AP (1) AP544A (da)
AT (1) ATE183643T1 (da)
AU (1) AU680918B2 (da)
BE (1) BE1007158A3 (da)
BR (1) BR1100046A (da)
CA (1) CA2162919C (da)
CO (1) CO4230094A1 (da)
CY (1) CY2411B1 (da)
CZ (1) CZ291041B6 (da)
DE (1) DE69420266T2 (da)
DK (1) DK0700290T3 (da)
EC (1) ECSP941088A (da)
ES (1) ES2136198T3 (da)
FR (1) FR2705569B1 (da)
GB (2) GB9310756D0 (da)
GR (1) GR3031669T3 (da)
HR (2) HRP940315B1 (da)
HU (1) HU227121B1 (da)
IE (1) IE80632B1 (da)
IL (1) IL109749A (da)
IS (1) IS1868B (da)
IT (1) IT1272990B (da)
MY (1) MY111445A (da)
NO (1) NO306448B1 (da)
NZ (1) NZ267415A (da)
PE (1) PE13395A1 (da)
PL (1) PL175578B1 (da)
RU (1) RU2132684C1 (da)
SA (1) SA94150003B1 (da)
SG (1) SG48119A1 (da)
SI (1) SI0700290T1 (da)
WO (1) WO1994027599A1 (da)
ZA (1) ZA943593B (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1464333A3 (en) * 1998-06-15 2004-12-15 Sepracor Inc. Use of optically pure (-) norcisapride in the treatment of apnea, bulimia, and other disorders
EP1468685A3 (en) * 1998-06-15 2004-12-15 Sepracor Inc. Use of optically pure (+)-norcisapride for treating apnea, bulimia and other disorders
SK19062000A3 (sk) * 1998-06-15 2001-07-10 Sepracor, Inc. Použitie (-)-norcisapridu alebo jeho farmaceuticky prijateľnej soli, v podstate bez jeho (+) stereoizoméru, na liečenie apnoe, bulímie a iných porúch
BR9911299A (pt) * 1998-06-15 2001-03-13 Sepracor Inc Processos para tratar bulimia, para tratar distúrbios mediados por atividade vagal, para tratar sìndrome de intestino irritável, para tratar bradicardia ou bradiarritmia, para tratar asma, para tratar incontinência urinária, para tratar apnéia ou distúrbios de apnéia,ou distúrbios de apnéia, para prevenir ou controlar bulimia, distúrbios mediados por atividade vagal, sìndrome de intestino irritável, bradicardia ou bradiarritmia, asma, incontinência urinária, e, apnéia ou distúrbios da apnéia, em um paciente
US6362202B1 (en) 1999-03-02 2002-03-26 Sepracor Inc. Methods and compositions using (−) norcisapride in combination with proton pump inhibitors or H2 receptor antagonists
US6353005B1 (en) 1999-03-02 2002-03-05 Sepracor, Inc. Method and compositions using (+) norcisapride in combination with proton pump inhibitors or H2 receptor antagonist
BR0112969A (pt) * 2000-08-04 2004-06-22 Dmi Biosciences Inc Método de utilização de dicetopiperazinas e composições contendo-as

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4695578A (en) * 1984-01-25 1987-09-22 Glaxo Group Limited 1,2,3,9-tetrahydro-3-imidazol-1-ylmethyl-4H-carbazol-4-ones, composition containing them, and method of using them to treat neuronal 5HT function disturbances
DE3502508A1 (de) * 1984-01-25 1985-08-14 Glaxo Group Ltd., London Heterocyclische verbindungen
GB8627909D0 (en) * 1986-11-21 1986-12-31 Glaxo Group Ltd Medicaments
GB8816187D0 (en) * 1988-07-07 1988-08-10 Glaxo Group Ltd Medicaments
US5166145A (en) * 1990-09-10 1992-11-24 Alza Corporation Antiemetic therapy

Also Published As

Publication number Publication date
ATE183643T1 (de) 1999-09-15
IE940420A1 (en) 1994-11-30
JPH08510457A (ja) 1996-11-05
SG48119A1 (en) 1998-04-17
PE13395A1 (es) 1995-05-25
IS4168A (is) 1994-11-26
GB2279008B (en) 1997-06-18
MY111445A (en) 2000-05-31
CY2411B1 (en) 2004-11-12
CN1106194C (zh) 2003-04-23
BE1007158A3 (fr) 1995-04-11
HRP940315B1 (en) 2000-12-31
AP9400643A0 (en) 1994-07-31
CZ308595A3 (en) 1996-06-12
CZ291041B6 (cs) 2002-12-11
NO954783L (no) 1995-11-24
SI0700290T1 (en) 1999-12-31
FR2705569B1 (fr) 1995-11-10
DE69420266D1 (de) 1999-09-30
IT1272990B (it) 1997-07-01
ECSP941088A (es) 1994-11-16
US5741806A (en) 1998-04-21
AP544A (en) 1996-10-11
CO4230094A1 (es) 1995-10-19
EP0700290A1 (en) 1996-03-13
RU2132684C1 (ru) 1999-07-10
AU6970994A (en) 1994-12-20
EP0700290B1 (en) 1999-08-25
ITRM940322A0 (it) 1994-05-24
NO306448B1 (no) 1999-11-08
GB9409835D0 (en) 1994-07-06
GB9310756D0 (en) 1993-07-14
HUT74867A (en) 1997-02-28
FR2705569A1 (fr) 1994-12-02
PL311721A1 (en) 1996-03-04
ZA943593B (en) 1995-02-13
BR1100046A (pt) 1999-11-23
IS1868B (is) 2003-05-02
AU680918B2 (en) 1997-08-14
IL109749A (en) 1999-03-12
GB2279008A (en) 1994-12-21
JP2965703B2 (ja) 1999-10-18
HRP940315A2 (en) 1996-08-31
DE69420266T2 (de) 1999-12-09
NZ267415A (en) 1997-10-24
CN1124454A (zh) 1996-06-12
IL109749A0 (en) 1994-08-26
PL175578B1 (pl) 1999-01-29
HU227121B1 (en) 2010-07-28
IE80632B1 (en) 1998-10-21
ITRM940322A1 (it) 1995-11-24
NO954783D0 (no) 1995-11-24
CA2162919A1 (en) 1994-12-08
CA2162919C (en) 1999-07-20
SA94150003B1 (ar) 2005-04-11
HU9503375D0 (en) 1996-01-29
KR100297212B1 (ko) 2001-10-24
HRP970315A2 (en) 1999-04-30
ES2136198T3 (es) 1999-11-16
GR3031669T3 (en) 2000-02-29
WO1994027599A1 (en) 1994-12-08

Similar Documents

Publication Publication Date Title
FI931229A0 (fi) Som glanspigment laempade blandningar
FI933167A0 (fi) N-alkylkinuklidiniumsalter som substans-p antagonister
DE69321338D1 (de) Crocetin enthaltendes Färbemittel
NO961432D0 (no) Benzofiofener og beslektede forbindelser som östrogen-agonister
FI921182A (fi) Velangummi som snabbt hydratiseras
DE69433878D1 (de) Kühlkörper
FI931069A (fi) Kolloidalt rostat kaffe som aromatiseringsprodukt
FI931111A0 (fi) Staongtvaolskompositioner som innehaoller sackaros
FI934225A0 (fi) Bis-naftalimider innehaollande ur aminosyror haerledda kopplingsaemnen som anticancermedel
FI922973A (fi) Tokoferolblandning foer anvaendning som antioxidant foer krusmyntolja i tuggummi
FI934751A0 (fi) Extracellulaera matrisreceptorligander som modulerar leukocytfunktioner
FI933022A0 (fi) Radiosystem som bildar en traodloes lokalslinga
FI932454A0 (fi) Ansiktsemulsionskompositioner som laemnas pao huden
DK0700290T3 (da) Rektale præparater indeholdende odansentron som fri base
FI934764A (fi) Anordning som hindrar krympning av kabelisolering
FI930342A (fi) Pentapeptider som reglerar immun- och nervsystem
KR930003344U (ko) 고정식 표지판
KR950000305U (ko) 햄먹(hammock)
FI934219A0 (fi) Foerbandsbalkkonstruktion som huvudsaklig baerare foer mellanbjaelklag i flervaeningshus (tt-foerbandsbalk)
FIU920317U0 (fi) Loestagbar barnstol som tillaeggsutrustning till koekstrappa
KR960700237A (ko) 치환된 신규 티오쎄미카르바존티온류(Novel Substituted Thiosemicarbazonethiones)
FI554U1 (fi) Reklam som aendrar faerg
FI922997A (fi) Tuggummi som innehaoller verksamma aemnen
KR940026091U (ko) 거울 받침구
FI931598A0 (fi) Spelbraede foer som bokstavplattor formade spelbrickor